← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Dabigatran etexilato currently has availability issues reported in 4 European registers: Austria, Germany, Spain, Italy.
Shortage ATC B01AE07 · also listed as: DABIGATRANETEXILATMESILAT · DABIGATRAN ETEXILATO · DABIGATRAN ETEXILATO MESILATO · data refreshed 21 September 2026
As of 21 September 2026, 4 of the 8 tracked registers list current availability issues for Dabigatran etexilato, covering 20 affected product presentations. The longest-running open report was filed in Spain on 2025-10-30 and has now been open for about 11 months. Where agencies state a cause, manufacturing problems lead with 8 of the 10 stated-cause reports, followed by unexpectedly high demand with 2. The furthest expected-resolution date currently on file is 2026-12-15; the earliest is 2026-10-06. Momentum is current, not historical: 10 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Spain reported first (2025-10-30), with Germany following roughly 6 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Dabigatran etexilato is coded B01AE07 — a medicine acting on blood and blood-forming organs — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Shortage Dabahib 110 mg-Hartkapseln + 7 more productsDabahib 150 mg-Hartkapseln Dabahib 75 mg-Hartkapseln Dabigatranetexilat 1A Pharma 110 mg - Hartkapseln Dabigatranetexilat 1A Pharma 150 mg - Hartkapseln Dabigatranetexilat 1A Pharma 75 mg - Hartkapseln Dabigatranetexilat Viatris 150 mg Hartkapseln Dabigatranetexilat Viatris 75 mg Hartkapseln | 2025-10-30 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Dabigatranetexilat Viatris 110 mg Hartkapseln + 2 more productsDabigatranetexilat Viatris 150 mg Hartkapseln Dabigatranetexilat Viatris 75 mg Hartkapseln | 2026-04-21 | 2026-12-15 | Probleme beim Wirkstoffhersteller Alternatives: N/A | register ↗ |
| 🇪🇸 Spain | Shortage DABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG, 30 cápsulas + 4 more productsDABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG, 60 cápsulas DABIGATRAN ETEXILATO TEVA 110 MG CAPSULAS DURAS EFG, 10 cápsulas DABIGATRAN ETEXILATO VIATRIS 110 MG CÁPSULAS DURAS EFG, 60 cápsulas DABIGATRAN ETEXILATO VIATRIS 150 MG CÁPSULAS DURAS EFG, 60 cápsulas | 2025-10-30 | 2026-11-02 | Existen otros medicamentos con el mismo principio activo y misma vía. Alternatives: Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración. | register ↗ |
| 🇮🇹 Italy | Shortage DABIGATRAN ETEXILATO ACCORD + 6 more productsDABIGATRAN ETEXILATO EG STADA DABIGATRAN ETEXILATO MEDICAL VALLEY DABIGATRAN ETEXILATO MEDICAL VALLEY DABIGATRAN ETEXILATO VIATRIS DABIGATRAN ETEXILATO VIATRIS DABIGATRAN ETEXILATO VIATRIS | 2026-01-02 | 2026-10-31 | Elevata richiesta Alternatives: AIFA: equivalents with the same active substance are available. | register ↗ |
Every individual register entry for Dabigatran etexilato in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | DABIGATRAN ETEXILATO VIATRIS | Shortage | 2026-11-20 | — | Problemi produttivi |
| 🇮🇹 IT | DABIGATRAN ETEXILATO EG STADA | Shortage | 2026-09-24 | — | Problemi produttivi (carenza relativa solo al canale retail) |
| 🇮🇹 IT | DABIGATRAN ETEXILATO VIATRIS | Shortage | 2026-09-10 | — | Problemi produttivi |
| 🇪🇸 ES | DABIGATRAN ETEXILATO VIATRIS 150 MG CÁPSULAS DURAS EFG, 60 cápsulas | Shortage | 2026-09-02 | 2026-10-06 | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | DABIGATRAN ETEXILATO VIATRIS 110 MG CÁPSULAS DURAS EFG, 60 cápsulas | Shortage | 2026-08-19 | 2026-11-02 | Existen otros medicamentos con el mismo principio activo y m |
| 🇩🇪 DE | Dabigatranetexilat Viatris 110 mg Hartkapseln | Shortage | 2026-08-06 | 2026-11-16 | Probleme beim Wirkstoffhersteller |
| 🇩🇪 DE | Dabigatranetexilat Viatris 75 mg Hartkapseln | Shortage | 2026-08-06 | 2026-12-15 | Probleme beim Wirkstoffhersteller |
| 🇦🇹 AT | Dabigatranetexilat Viatris 150 mg Hartkapseln | Limited availability | 2026-07-30 | — | |
| 🇮🇹 IT | DABIGATRAN ETEXILATO ACCORD | Shortage | 2026-07-22 | — | Elevata richiesta |
| 🇪🇸 ES | DABIGATRAN ETEXILATO TEVA 110 MG CAPSULAS DURAS EFG, 10 cápsulas | Shortage | 2026-07-13 | 2026-10-11 | Existen otros medicamentos con el mismo principio activo y m |
| 🇦🇹 AT | Dabigatranetexilat Viatris 75 mg Hartkapseln | Limited availability | 2026-06-22 | — | |
| 🇦🇹 AT | Dabigatranetexilat 1A Pharma 110 mg - Hartkapseln | Limited availability | 2026-05-27 | — | |
| 🇮🇹 IT | DABIGATRAN ETEXILATO VIATRIS | Shortage | 2026-05-15 | — | Problemi produttivi |
| 🇮🇹 IT | DABIGATRAN ETEXILATO MEDICAL VALLEY | Shortage | 2026-05-01 | 2026-10-31 | Elevata richiesta/problemi produttivi (carenza relativa solo |
| 🇩🇪 DE | Dabigatranetexilat Viatris 150 mg Hartkapseln | Shortage | 2026-04-21 | 2026-11-16 | Erhöhte Nachfrage |
| 🇦🇹 AT | Dabigatranetexilat 1A Pharma 75 mg - Hartkapseln | Limited availability | 2026-04-09 | — | |
| 🇦🇹 AT | Dabigatranetexilat 1A Pharma 150 mg - Hartkapseln | Shortage | 2026-04-07 | — | |
| 🇮🇹 IT | DABIGATRAN ETEXILATO MEDICAL VALLEY | Shortage | 2026-01-02 | 2026-10-31 | Elevata richiesta/problemi produttivi (carenza relativa solo |
| 🇦🇹 AT | Dabahib 110 mg-Hartkapseln | Resolved | 2025-12-12 | — | |
| 🇦🇹 AT | Dabahib 150 mg-Hartkapseln | Resolved | 2025-12-12 | — | |
| 🇦🇹 AT | Dabahib 75 mg-Hartkapseln | Resolved | 2025-10-30 | — | |
| 🇪🇸 ES | DABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG, 30 cápsulas | Shortage | 2025-10-30 | 2026-10-27 | Existen otros medicamentos con el mismo principio activo y m |
| 🇪🇸 ES | DABIGATRAN ETEXILATO SANDOZ 75 MG CAPSULAS DURAS EFG, 60 cápsulas | Shortage | 2025-10-30 | — | Existen otros medicamentos con el mismo principio activo y m |
Yes. As of 21 September 2026, availability issues are reported in: Austria, Germany, Spain, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-10-06 to 2026-12-15. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
15 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Dabigatran etexilato: BASG (Austria), BfArM (Germany), AEMPS CIMA (Spain), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Dabigatran etexilato — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dabigatran-etexilato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Dabigatran etexilato availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dabigatran-etexilato/">Dabigatran etexilato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>